XML 83 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814
Reconciliations of Equity - Reconciliations of Total Equity (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Reconciliations of total equity        
Beginning Balance     $ 536,944 $ 553,741
Beginning Balance     535,546  
Beginning Balance     1,398  
Net income $ 24,934 $ 13,480 63,161 50,856
Net income 22 (11) 65 (6)
Dividends     (12,067) (11,381)
Common stock purchases [1]     (2,273) (6,723)
Stock option exercises     431 1,563
Pension liability adjustment, net of tax (Note 10) 722 429 2,221 1,249
Translation adjustments (19,793) (19,521) (38,988) (15,709)
Derivative instrument activity, net of tax (14) 2 (40) 6
Other [2]     3,617 2,241
Ending Balance 553,006 575,843 553,006 575,843
Ending Balance 551,584   551,584  
Ending Balance 1,422   1,422  
Noncontrolling Interests' Equity [Member]        
Reconciliations of total equity        
Beginning Balance [3]     1,398 1,455
Net income [3]     65 (6)
Translation adjustments [3]     (41) (22)
Ending Balance [3] 1,422 1,427 1,422 1,427
Stepan Company Equity [Member]        
Reconciliations of total equity        
Beginning Balance     535,546 552,286
Net income     63,096 50,862
Dividends     (12,067) (11,381)
Common stock purchases [1]     (2,273) (6,723)
Stock option exercises     431 1,563
Pension liability adjustment, net of tax (Note 10)     2,221 1,249
Translation adjustments     (38,947) (15,687)
Derivative instrument activity, net of tax     (40) 6
Other [2]     3,617 2,241
Ending Balance $ 551,584 $ 574,416 $ 551,584 $ 574,416
[1] Includes the value of Company shares purchased in the open market and the value of Company common shares tendered by employees to settle minimum statutory withholding taxes related to the receipt of performance awards and deferred compensation distributions.
[2] Primarily comprised of activity related to stock-based compensation, deferred compensation and excess tax benefits.
[3] Reflects the noncontrolling interest in the Company’s China joint venture.